Sfoglia per Rivista  FUTURE ONCOLOGY

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 13 a 24 di 24
Titolo Data di pubblicazione Autore(i) File
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer) 1-gen-2023 Abou-Alfa, Ghassan K; Lau, George; Kudo, Masatoshi; Chan, Stephen L; Kelley, Robin Kate; Furuse, Junji; Sukeepaisarnjaroen, Wattana; Kang, Yoon Koo; Dao, Tu Van; De Toni, Enrico N; Rimassa, Lorenza; Breder, Valeriy; Vasilyev, Alexander; Heurgué, Alexandra; Tam, Vincent C; Mody, Kabir; Thungappa, Satheesh Chiradoni; Ostapenko, Yurii; Yau, Thomas; Azevedo, Sergio; Varela, María; Cheng, Ann-Lii; Qin, Shukui; Galle, Peter R; Ali, Sajid; Gupta, Charu; Makowsky, Mallory; Kurland, John F; Negro, Alejandra; Sangro, Bruno
Postoperative radiotherapy with volumetric modulated arc therapy of lacrimal gland carcinoma: two case reports and literature review 1-gen-2014 Orlandi, E; Takanen, S; Giandini, T; Iannacone, E; Fontanella, W; Locati, L; Carrara, M; Bossi, P; Bergamini, C; Granata, R; Tombolini, V; Ibba, T; Licitra, L; Pignoli, E; Fallai, C
Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough 1-gen-2017 Fornaro, L; Fanotto, V; Musettini, G; Bordonaro, R; Rimassa, L; Vivaldi, C; Fontanella, C; Leone, F; Giampieri, R; Rosati, G; Lencioni, M; Santini, D; Di Donato, S; Tomasello, G; Brunetti, O; Pietrantonio, F; Bergamo, F; Scartozzi, M; Avallone, A; Lutrino, Se; Melisi, D; Antonuzzo, L; Pellegrino, A; Gerratana, L; Cordio, S; Vasile, E; Aprile, G
Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer 1-gen-2019 Rossi, S; Finocchiaro, G; Di Noia, V; Bonomi, M; Cerchiaro, E; De Rose, F; Franceschini, D; Navarria, P; Ceresoli, Gl; Beretta, Gd; D'Argento, E; Scorsetti, M; Santoro, A; Toschi, L
Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy 1-gen-2019 Bossi, P.; Botta, L.; Bironzo, P.; Sonetto, C.; Musettini, G.; Sbrana, A.; Di Giannantonio, V.; Locati, L. D.; Di Maio, M.; Antonuzzo, A.
Targeted therapy for thymic epithelial tumors: a new horizon ? Review of the literature and two cases reports 1-gen-2015 Simonelli, M; Zucali, PAOLO ANDREA; Suter, M B; Lorenzi, E; Rubino, L; Fatuzzo, G; Alloisio, M; Santoro, A
Tivantinib: a new promising mesenchymal-epithelial transition factor inhibitor in the treatment of hepatocellular carcinoma 1-gen-2013 Rimassa, L; Personeni, N; Simonelli, M; Santoro, A
Trabectedin mechanism of action: what's new? 1-gen-2013 D'Incalci, M
Vismodegib in the treatment of basal cell carcinoma: indications for clinical practice 1-gen-2015 Calzavara Pinton, P; Licitra, L; Peris, K; Santoro, A; Ascierto, Pa
What do you think about these data regarding trabectedin plus PLD in fully sensitive patients? 1-gen-2013 Lorusso, D
What do you usually do in your hospital when a patient develops hypersensitivity to platinum? 1-gen-2013 del Campo, Jm; Sehouli, J; Lorusso, D
What is the importance of the sequence of treatment? 1-gen-2013 Lorusso, D
Mostrati risultati da 13 a 24 di 24
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile